Our interdisciplinary team of scientists collaborates to develop nanovaccines and nanotherapeutics
We are developing a universal influenza nanovaccine that would be effective against more strains of flu than current flu shots
For cancers, we are researching tumor-specific targets for nanotherapeutics
Nanovaccines can prevent tropical diseases such as malaria and filariasis
Nanotherapeutics use lower dosages than systemic drugs, allowing life-saving drugs to be used for young children
Nanoparticles can deliver therapeutic agents across the blood-brain barrier to treat neural disorders such as Alzheimer's, Parkinson's, and traumatic brain injury
Nanotechnologies can help optimize aging via improved biosensing capabilities and vaccine delivery
Researching veterinary diseases such as swine flu, avian flu, and bovine respiratory syncytial virus can help design nanovaccines to prevent similar diseases in humans
No needles, no boosters: extended-release nanovaccines can be delivered by nasal inhaler rather than injection
Nanovaccines don't need refrigeration (polio campaign worker in India carrying styrofoam cooler for vaccine)
Nanoparticles average only 300 nanometers in diameter, 1000 times smaller than the period at the end of a sentence.
Nasal Vaccines for COVID-19 – better at blocking transmission?
Despite an arsenal of highly effective injectable vaccines, drugmakers are looking into products that will be easier to store, transport, and administer in the global crisis -- particularly, … Read more
Iowa State Awards Vaccines & Immunotherapeutics Seed Grants to Nanovaccine Institute Researchers
To support innovation and advancements in the biosciences, Iowa State University is working in partnership with the Iowa Economic Development Authority and the Iowa Innovation Corporation to offer … Read more
Skroot Laboratory, Inc. spins off from Iowa State research, helps labs make medicine
It’s necessary work for a cell factory, but monitoring cell growth in small flasks is labor intensive and risks contaminating cell cultures. It can be a bit of lab drudgery, too.
“I did this … Read more
St. Jude influenza research earns renewed National Institutes of Health funding
Centers of Excellence for Influenza Research and Response at St. Jude earns nearly $9 million in funding
The National Institute of Allergy and Infectious Diseases, (NIAID), an affiliate of … Read more